Chantal Babb de Villiers

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Genome Wide Association

Top Venues

Journal of medical genetics

Journal of medical virology

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Mwiza Gideon Singini, Elvira Singh, Debbie Bradshaw, Thendo Ramaliba, Wenlong Carl Chen, Melitah Motlhale, Abram Bunya Kamiza, Chantal Babb de Villiers, Mazvita Sengayi, Christopher G Mathew, Robert Newton, Noemi Bender, Tim Waterboer, Frederic Sitas
Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis. Journal of medical virology (2022)
Sowmiya A Moorthie, Alison Hall, Chantal Babb de Villiers, Joanna Janus, Tanya Brigden, Laura Blackburn, Mark Kroese
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests? Personalized medicine 19 (3) (2022)
Chantal Babb de Villiers, Mark Kroese, Sowmiya Moorthie
Understanding polygenic models, their development and the potential application of polygenic scores in healthcare. Journal of medical genetics 57 (11) (2020)
Stephanie Archer, Chantal Babb de Villiers, Fiona Scheibl, Tim Carver, Simon Hartley, Andrew J Lee, Alex P Cunningham, Douglas F Easton, Jennifer G McIntosh, Jon Emery, Marc Tischkowitz, Antonis C Antoniou, Fiona M Walter
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study. PloS one 15 (3) (2020)
Tim Carver, Simon Hartley, Andrew J Lee, Alex P Cunningham, Stephanie Archer, Chantal Babb de Villiers, Jonathan Roberts, Rod Ruston, Fiona Mary Walter, Marc Tischkowitz, Douglas F Easton, Antonis C Antoniou
CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30 (3) (2020)